Gender Difference in Cisplatin-Induced Nephrotoxicity in a Rat Model: Greater Intensity of Damage in Male Than Female
Nephro-Urology Monthly · 25.06.2013 · 5 (3) · 818-21
DOI: 10.5812/numonthly.10128 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nephro-Urology Monthly, online erschienen am 25.06.2013. Verfasst von Mehdi Nematbakhsh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Water and Electrolytes Research Center, Isfahan University of Medical Sciences, Isfahan, IR Iran ; Department of Physiology, Isfahan University of Me…. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Water and Electrolytes Research Center, Isfahan University of Medical Sciences, Isfahan, IR Iran ; Department of Physiology, Isfahan University of Medical Sciences, Isfahan, IR Iran ; Kidney Diseases Research Center, Is…
Zitieren
APA
Nematbakhsh, M., Ebrahimian, S., Tooyserkani, M., Eshraghi-Jazi, F., Talebi, A., & Ashrafi, F. (2013). Gender Difference in Cisplatin-Induced Nephrotoxicity in a Rat Model: Greater Intensity of Damage in Male Than Female. Nephro-Urology Monthly, 5(3), 818-21. https://doi.org/10.5812/numonthly.10128
Vancouver
Nematbakhsh M, Ebrahimian S, Tooyserkani M, Eshraghi-Jazi F, Talebi A, Ashrafi F. Gender Difference in Cisplatin-Induced Nephrotoxicity in a Rat Model: Greater Intensity of Damage in Male Than Female. Nephro-Urology Monthly. 2013;5(3):818-21. doi:10.5812/numonthly.10128
BibTeX
@article{Nematbakhsh2013,
author = {Nematbakhsh, Mehdi and Ebrahimian, Shadi and Tooyserkani, Mona and Eshraghi-Jazi, Fatemeh and Talebi, Ardeshir and Ashrafi, Farzaneh},
title = {Gender Difference in Cisplatin-Induced Nephrotoxicity in a Rat Model: Greater Intensity of Damage in Male Than Female},
journal = {Nephro-Urology Monthly},
year = {2013},
volume = {5},
number = {3},
pages = {818--21},
doi = {10.5812/numonthly.10128}
}
EUVIMED